Outer membrane vesicles: A bacterial-derived vaccination system
- PMID: 36620013
- PMCID: PMC9811673
- DOI: 10.3389/fmicb.2022.1029146
Outer membrane vesicles: A bacterial-derived vaccination system
Abstract
Outer membrane vesicles (OMVs) are non-living spherical nanostructures that derive from the cell envelope of Gram-negative bacteria. OMVs are important in bacterial pathogenesis, cell-to-cell communication, horizontal gene transfer, quorum sensing, and in maintaining bacterial fitness. These structures can be modified to express antigens of interest using glycoengineering and genetic or chemical modification. The resulting OMVs can be used to immunize individuals against the expressed homo- or heterologous antigens. Additionally, cargo can be loaded into OMVs and they could be used as a drug delivery system. OMVs are inherently immunogenic due to proteins and glycans found on Gram negative bacterial outer membranes. This review focuses on OMV manipulation to increase vesiculation and decrease antigenicity, their utility as vaccines, and novel engineering approaches to extend their application.
Keywords: bacteria; glycoengineering; lipopolysaccharide; outer membrane vesicle; vaccine.
Copyright © 2022 Lieberman.
Conflict of interest statement
LL was employed by Merck & Co., Inc.
Figures
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources